News

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...
A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...
A new study published in the New England Journal of Medicine reveals that medications widely used for diabetes and obesity ...
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
So, there's this scientist, Arun Sanyal, M.D., who's the director of the VCU Stravitz-Sanyal Institute for Liver Disease and ...
A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...